New shot aims to save Insulin-Making cells in type 1 diabetes
NCT ID NCT03895437
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study tested an experimental drug called TOL-3021 in people with type 1 diabetes to see if it could help preserve the body's ability to produce insulin. Participants received either the drug or a placebo over 24 weeks, with follow-up for safety. The trial was stopped early, and results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altman Clinical and Translational Research Institute UCSD
San Diego, California, 92093, United States
-
Baptist Health Research Institute
Jacksonville, Florida, 32258, United States
-
Barbara Davis Center - University of Colorado Denver
Denver, Colorado, 80045, United States
-
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
-
Diabetes and Glandular Disease Clinic, P.A.
San Antonio, Texas, 78229, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Joslin Diabetes Center- Adult & Pediatric
Boston, Massachusetts, 02215, United States
-
MedStar Health Research Institute
Baltimore, Maryland, 21239, United States
-
MedStar Health Research Institute
Hyattsville, Maryland, 20782, United States
-
Mills-Peninsula Medical Center
San Mateo, California, 94401, United States
-
Mountain Diabetes and Endocrine Center
Asheville, North Carolina, 28803, United States
-
Naomi Berrie Diabetes Center, Columbia University
New York, New York, 10032, United States
-
Rocky Mountain Clinical Research
Idaho Falls, Idaho, 83404, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
-
Stanford University
Stanford, California, 94305, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of Florida
Gainesville, Florida, 32610, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Miami Diabetes Research Institute
Miami, Florida, 33136, United States
-
University of North Carolina Diabetes Care Center
Chapel Hill, North Carolina, 27517, United States
-
University of South Florida Diabetes Center
Tampa, Florida, 33612, United States
-
University of Virginia
Charlottesville, Virginia, 22903, United States
-
Yale University
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.